NEOGENOMICS INC — Director's Dealing 2017

Oct 3, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2017-08-09

Reporting Person: HANNAH ALISON L. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-08-09	Common Stock	M	6667	$6.66	Acquired	45449	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-08-09	Stock Option (Right to Buy)	$6.66	X	6667	Disposed	2020-07-15	Common Stock (6667)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$9.11	2021-07-28	Common Stock (8333)	8333	Direct
Stock Option (Right to Buy)	$7.27	2022-05-25	Common Stock (10000)	10000	Direct
Restricted Stock	$		Common Stock (8667)	8667	Direct

Footnotes

F1: On July 15, 2015 Alison Hannah was granted 10,000 stock options, the options vest ratably on the next three anniversary dates of the grant date. On 8/9/2017 6,667 of these options were exercised leaving a balance of 3,333.

F2: On July 28, 2016, Alison Hannah was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F3: On May 25, 2017, Alison Hannah was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.

F4: Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.

F5: The restricted stock will vest as follows; 2,166 units at June 30, 2017 and thereafter, 2,167 shares will vest on the last day of each calendar quarter for the next three fiscal quarters up to March 31, 2018.

F6: These restricted stock units will terminate upon the earliest of death, termination of employment or the last vesting date.